Yesterday, June 1, 2016, 85 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $11.31 to $40,830,885.00.

Highlighted Stocks Traded by Insiders:

TearLab (TEAR) - FREE Research Report

Wright Brock, who is Director at TearLab, bought 59,686 shares at $0.78 on June 1, 2016. Following this transaction, the Director owned 847,632 shares meaning that the stake was boosted by 7.57% with the 59,686-share transaction.

The shares most recently traded at $0.80, up $0.02, or 2.85% since the insider transaction. Historical insider transactions for TearLab go as follows:

  • 4-Week # shares bought: 496,978
  • 12-Week # shares bought: 496,978
  • 12-Week # shares sold: 7,000
  • 24-Week # shares bought: 496,978
  • 24-Week # shares sold: 7,000

The average volume for TearLab has been 138,000 shares per day over the past 30 days. TearLab has a market cap of $26.3 million and is part of the health care sector and health services industry. Shares are down 42.45% year-to-date as of the close of trading on Wednesday.

TearLab Corp. operates as an in-vitro diagnostic company in the United States. It is involved in developing and commercializing TearLab Osmolarity System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease. Currently, there are 3 analysts who rate TearLab a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on TEAR - FREE

TheStreet Quant Ratings

rates TearLab as a

sell

. Among the areas we feel are negative, one of the most important has been a generally disappointing historical performance in the stock itself. Get the full

TearLab Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

AMERISAFE (AMSF) - FREE Research Report

Shirley Kathryn Housh, who is EVP, General Counsel at AMERISAFE, sold 375 shares at $60.92 on June 1, 2016. Following this transaction, the EVP, General Counsel owned 13,397 shares meaning that the stake was reduced by 2.72% with the 375-share transaction.

The shares most recently traded at $61.23, up $0.31, or 0.51% since the insider transaction. Historical insider transactions for AMERISAFE go as follows:

  • 4-Week # shares sold: 833
  • 12-Week # shares sold: 3,839
  • 24-Week # shares sold: 63,764

The average volume for AMERISAFE has been 98,400 shares per day over the past 30 days. AMERISAFE has a market cap of $1.2 billion and is part of the financial sector and insurance industry. Shares are up 20.63% year-to-date as of the close of trading on Wednesday.

AMERISAFE, Inc., an insurance holding company, provides workers' compensation insurance in the United States. Its workers' compensation insurance policies provide benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. The stock currently has a dividend yield of 1.19%. The company has a P/E ratio of 14.3. Currently, there are 2 analysts who rate AMERISAFE a buy, no analysts rate it a sell, and none rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on AMSF - FREE

TheStreet Recommends

TheStreet Quant Ratings

rates AMERISAFE as a

buy

. The company's strengths can be seen in multiple areas, such as its revenue growth, notable return on equity, solid stock price performance, impressive record of earnings per share growth and compelling growth in net income. We feel its strengths outweigh the fact that the company shows weak operating cash flow. Get the full

AMERISAFE Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Dollar Tree (DLTR) - FREE Research Report

Jacobs David A., who is Chief Strategy Officer at Dollar Tree, sold 3,167 shares at $90.43 on June 1, 2016. Following this transaction, the Chief Strategy Officer owned 20,193 shares meaning that the stake was reduced by 13.56% with the 3,167-share transaction.

Matacunas Mike R., who is Chief Administrative Officer at Dollar Tree, sold 2,974 shares at $90.50 on June 1, 2016. Following this transaction, the Chief Administrative Officer owned 12,601 shares meaning that the stake was reduced by 19.09% with the 2,974-share transaction.

Witynski Michael A., who is Chief Operating Officer at Dollar Tree, sold 4,964 shares at $90.68 on June 1, 2016. Following this transaction, the Chief Operating Officer owned 6,535 shares meaning that the stake was reduced by 43.17% with the 4,964-share transaction.

The shares most recently traded at $91.20, up $0.52, or 0.57% since the insider transaction. Historical insider transactions for Dollar Tree go as follows:

  • 4-Week # shares bought: 3,500
  • 4-Week # shares sold: 62,616
  • 12-Week # shares bought: 3,500
  • 12-Week # shares sold: 85,861
  • 24-Week # shares bought: 3,500
  • 24-Week # shares sold: 85,861

The average volume for Dollar Tree has been 2.3 million shares per day over the past 30 days. Dollar Tree has a market cap of $21.3 billion and is part of the services sector and retail industry. Shares are up 17.6% year-to-date as of the close of trading on Wednesday.

Dollar Tree, Inc. operates discount retail stores in the United States and Canada. The company operates in two segments, Dollar Tree and Family Dollar. The Dollar Tree segment offers merchandise at the fixed price of $1.00. The company has a P/E ratio of 71.3. Currently, there are 11 analysts who rate Dollar Tree a buy, no analysts rate it a sell, and 9 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on DLTR - FREE

TheStreet Quant Ratings

rates Dollar Tree as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations, increase in net income, solid stock price performance and growth in earnings per share. We feel its strengths outweigh the fact that the company has had generally high debt management risk by most measures that we evaluated. Get the full

Dollar Tree Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.